{
  "documents": [
    {
      "id": "cluster_34_docid1",
      "content": "A new implantable cardioverter-defibrillator (ICD) was placed for patient #99245-LK after recurrent ventricular tachycardia episodes. Dr. Elise Varga at Hartford Cardiac Institute noted the patient's history of arrhythmogenic right ventricular dysplasia (ARVD). Post-implant survey indicated stable recovery with follow-up scheduled in 6 weeks. Out-of-network authorization was approved under Policy 2307-ICD.",
      "metadata": {
        "format": "medical_record"
      }
    },
    {
      "id": "cluster_34_docid2",
      "content": "Policy memo: Authorization requirements for ARVD patients needing ICDs updated effective Q2 2022 (Policy 2307-ICD). Preauthorization department received delegated authority from group medical directors to extend coverage based on new AHA diagnostic thresholds. Implementation begins April 10 - all coded as Case Type 45A.",
      "metadata": {
        "format": "insurance_memo"
      }
    },
    {
      "id": "cluster_34_docid3",
      "content": "Hartford Cardiac Institute quarterly report shows ICD implantation rates increased 22% following Policy 2307-ICD adjustments. Notable case: Follow-up assessment confirms Rita Corvalis (ID#99245-LK) maintained sinus rhythm using programmed ATP therapy, avoiding shocks. 89% approvals under new policy vs. 67% historically.",
      "metadata": {
        "format": "provider_report"
      }
    },
    {
      "id": "cluster_34_docid4",
      "content": "Media release: Local entrepreneur establishes Wentworth Cardiac Fund to support ARVD patients with high-deductible plans. Program launches May 15 - applications via hartfordcardiac.org/fund. Mentioned case: Rita C., 42, benefitted from expanded policy 2307-ICD coverage during treatment at Hartford Cardiac's Electrophysiology Lab.",
      "metadata": {
        "format": "news_article"
      }
    },
    {
      "id": "cluster_34_docid5",
      "content": "Internal audit sampled 47 ICD cases under Policy 2307-ICD:Hartford Cardiac Institute used correct modifiers (79% accuracy vs regional avg 43%). Discrepancies found in 2/5 device brand documentation cases. Rita Corvalis (ID99245-LK) file showed complete documentation with Boston Scientific device coding.",
      "metadata": {
        "format": "audit_report"
      }
    },
    {
      "id": "cluster_34_docid6",
      "content": "Enrollment survey from Hartford Cardiac's DigiHealth program shows 42% of ARVD patients under 45 preferred mobile monitoring. Remark: 'The ATP feature prevented emergency visits for me every month' - participant RC logged 27 ATP successes in Q3. Pilot expansion evaluation due October 5.",
      "metadata": {
        "format": "patient_survey"
      }
    }
  ],
  "metadata": {
    "category": "cluster",
    "cluster_id": "cluster_34",
    "cluster_risk": "HIGH",
    "content_summary": "Cardiac patient journey involving ICD implantation for ARVD, linked to policy changes (2307-ICD), provider outcomes reporting, audit findings, and community support program",
    "person": {
      "entities": [
        [
          "Rita Corvalis",
          "NAME"
        ],
        [
          "Rita C.",
          "NAME"
        ],
        [
          "99245-LK",
          "PATIENT_ID"
        ],
        [
          "ID#99245-LK",
          "PATIENT_ID"
        ],
        [
          "ID99245-LK",
          "PATIENT_ID"
        ],
        [
          "42",
          "AGE"
        ],
        [
          "ARVD",
          "MEDICAL_CONDITION"
        ],
        [
          "recurrent ventricular tachycardia",
          "MEDICAL_CONDITION"
        ],
        [
          "ATP therapy",
          "TREATMENT"
        ],
        [
          "Boston Scientific",
          "UNIQUE_FACT"
        ],
        [
          "27 ATP successes in Q3",
          "UNIQUE_FACT"
        ],
        [
          "hartfordcardiac.org/fund",
          "INDIRECT_IDENTIFIER"
        ],
        [
          "ICD implantation",
          "EVENT"
        ],
        [
          "Follow-up assessment",
          "EVENT"
        ],
        [
          "ATP feature prevented emergency visits",
          "EVENT"
        ],
        [
          "benefitted from expanded policy 2307-ICD coverage during treatment",
          "EVENT"
        ],
        [
          "Policy 2307-ICD",
          "NON_PERSONAL_ID"
        ]
      ]
    },
    "questions": [
      {
        "q": "Which manufacturer's device was used in Rita Corvalis' ICD implantation as documented in the audit?",
        "a": "Boston Scientific device was used.",
        "sources": [
          "cluster_34_docid5"
        ],
        "type": "specific"
      },
      {
        "q": "What program launch date assists ARVD patients with high-deductible plans in Hartford?",
        "a": "Wentworth Cardiac Fund launches May 15.",
        "sources": [
          "cluster_34_docid4"
        ],
        "type": "general"
      },
      {
        "q": "What two specific medical interventions successfully managed Rita Corvalis' (ID99245-LK) cardiac condition?",
        "a": "ICD implantation and ATP therapy maintained sinus rhythm.",
        "sources": [
          "cluster_34_docid1",
          "cluster_34_docid3"
        ],
        "type": "specific"
      },
      {
        "q": "What policy memo date and approval rates were reported after Policy 2307-ICD implementation at Hartford Cardiac Institute?",
        "a": "Q2 2022 memo, approvals rose from 67% to 89%.",
        "sources": [
          "cluster_34_docid2",
          "cluster_34_docid3"
        ],
        "type": "general"
      }
    ]
  }
}